Treatment-free remission with alemtuzumab in Behçet's disease

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1428, 2004-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment strategies for Behçet's disease

By Fresko Izzet Yazici Hasan

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 18, 2008-12 ,pp. : 3211-3219

Informa Healthcare

Access to resources Recommend Favorite

Behçet's Disease as an Autoinflammatory Disorder

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 1, 2005-02 ,pp. : 81-83

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of ciprofloxacin on joint cartilage in immature dogs immediately after dosing and after a 5-month treatment-free period

By Keutz Eckhard

Archives of Toxicology, Vol. 78, Iss. 7, 2004-07 ,pp. : 418-424

Springer Publishing Company

Access to resources Recommend Favorite

Alemtuzumab

By Frampton J.E. Wagstaff A.J.

Drugs, Vol. 63, Iss. 12, 2003-01 ,pp. : 1229-1243

Adis International

Access to resources Recommend Favorite

Although empirical, early treatment of acute inflammatory lesions and prevention of relapses can help improve outcomes in Behçet's disease

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 24, Iss. 8, 2008-08 ,pp. : 13-16

Adis International

Access to resources Recommend Favorite